Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141 | -150 | -329 | -106 | -990 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 160 |
| Other Working Capital | 0 | 3 | -394 | 194 | -1,080 |
| Other Operating Activity | 4 | 0 | -66 | -141 | 510 |
| Operating Cash Flow | $-137 | $-147 | $-789 | $-53 | $-1,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -552 | N/A | 1,217 | -156 | N/A |
| PPE Investments | N/A | 0 | N/A | 35 | -20 |
| Other Investing Activity | 61 | 38 | 97 | 192 | 550 |
| Investing Cash Flow | $-492 | $39 | $1,314 | $71 | $530 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -35 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -6 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-35 | $-6 |
| Beginning Cash Position | 808 | 916 | 391 | 408 | 1,280 |
| End Cash Position | 180 | 808 | 916 | 391 | 400 |
| Net Cash Flow | $-628 | $-108 | $525 | $-17 | $-880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137 | -147 | -789 | -53 | -1,400 |
| Free Cash Flow | -137 | -147 | -789 | -53 | -1,400 |